Protagonist Therapeutics
PTGX
$24.66
Share price
-4.05%
Change (1 day)
3.83%
Change (1 year)
Categories
Market capitalization of Protagonist Therapeutics (PTGX)
Market cap: $1.43 Billion
As of April 2024 Protagonist Therapeutics has a market cap of $1.43 Billion. This makes Protagonist Therapeutics the world's 4600th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Protagonist Therapeutics from 2016 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.43 B | 8.66% |
| 2023 | $1.32 B | 146.4% |
| 2022 | $0.53 B | -67.12% |
| 2021 | $1.63 B | 88.21% |
| 2020 | $0.86 B | 351.97% |
| 2019 | $0.19 B | 22.96% |
| 2018 | $0.15 B | -64.29% |
| 2017 | $0.43 B | 18.89% |
| 2016 | $0.36 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of Protagonist Therapeutics was reported to be:
$1.49 Billion
$1.49 Billion
$1.49 Billion
$1.49 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.51 B | -64.04% | 🇺🇸 USA |